Liposome encapsulated electron donor strategy for signal-on CYFRA 21-1 photoelectrochemical analysis

Rui Xu,Yu Du,Lei Liu,Dawei Fan,Xiang Ren,Xuejing Liu,Qin Wei,Huangxian Ju
DOI: https://doi.org/10.1007/s00604-021-04721-4
IF: 5.7
2021-02-09
Microchimica Acta
Abstract:A novel electron donor controlled-release system is proposed based on liposome encapsulated L-cysteine for the sensitive determination of cytokeratin 19 fragment 21–1 (CYFRA 21-1). On the one hand, a defective TiO<sub>2</sub> modified with methylene blue was employed as a photoactive platform which exhibited a high photoelectrochemical (PEC) response owing to the introduction of oxygen vacancies and the high  photosensitivity of the dye. On the other hand, L-cysteine as the sacrificial electron donor was encapsulated in the vesicles of liposomes, and this composite was used as the signal amplification factor, which is labeled on the secondary antibody of CYFRA 21-1 to further improve the photocurrent sensitivity. The excellent electron transfer path in photoactive materials coupled with the skilful electron donor controlled-release system, contributed to the sensitive  PEC analysis of CYFRA 21-1 underoptimum conditions. The PEC immunoassay showed a linear current response in the range 0.0001–100 ng/mL with a detection limitof 37 fg/mL. Enhanced stability and satisfactory reproducibility were also achieved. The proposed concept  provides a novel signal-on strategy for the sensitive detection of other cancer markers in the electrochemical sensing field.
chemistry, analytical
What problem does this paper attempt to address?
The problem this paper attempts to address is the development of a novel photoelectrochemical (PEC) immunosensor for the sensitive detection of cytokeratin 19 fragment 21-1 (CYFRA 21-1). CYFRA 21-1 is an important lung cancer biomarker, especially in non-small cell lung cancer. Although existing detection methods can detect CYFRA 21-1, their sensitivity and detection range are limited. Therefore, this paper proposes a signal enhancement strategy based on liposome-encapsulated electron donors to improve the sensitivity and stability of the detection. Specifically, the main contributions of the paper include: 1. **Modification of photosensitive materials**: By introducing oxygen vacancies and doping with iron ions (Fe³⁺), the photosensitivity of titanium dioxide (TiO₂) is improved, resulting in a higher photoelectrochemical response under visible light. 2. **Controlled release of electron donors**: L-cysteine (a common amino acid) is encapsulated in liposomes as an electron donor. This encapsulation method can effectively control the release of the electron donor, thereby enhancing the sensor's signal response. 3. **Construction of the biosensor**: Through a layer-by-layer assembly method, the modified photosensitive materials and liposome-encapsulated electron donors are integrated into a photoelectrochemical immunosensor, achieving high sensitivity detection of CYFRA 21-1. Experimental results show that the sensor exhibits a linear response in the concentration range of 0.0001 to 100 ng/mL, with a detection limit as low as 37 fg/mL, and has good stability and reproducibility. This method provides new ideas and technical foundations for the detection of other cancer biomarkers.